A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.
Also called NCT06979362
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT06979362 -
jRCT2031250304
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada, Germany, India, Japan, Poland, South Korea, Spain, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT06979362. Randomized; quadruple masking; primary purpose treatment. Start 2025-06-27 (actual); primary completion 2027-11-16 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- Acronym
- 8212-Preserved
- Condition
- Heart Failure
- Intervention (Drug)
- CDR132L
- Intervention (Drug)
- Placebo
- Lead sponsor
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct06979362- Content hash
90a69ed725c69e47eb49edb0e7178b0f2b8539238a267b65e30185a95fec2040